登陆
当前位置: 首页 >> 检索结果

结果排序

文献格式

出版时间

出版类型

出版语言
共有 132541 条符合本次的查询结果， 用时 3.7638277 秒

2821. Multimorbidity: health care that counts "past one" for 1·2 billion older adults - Author's reply.

作者: Sube Banerjee.
来源: Lancet. 2015年385卷9984期2253-4页

2822. ISAT: end of the debate on coiling versus clipping? - Authors' reply.

作者: Andrew J Molyneux.;Jacqueline Birks.;Richard S C Kerr.
来源: Lancet. 2015年385卷9984期2252页

2823. Multimorbidity: health care that counts "past one" for 1·2 billion older adults.

作者: Paul Kowal.;Perianayagam Arokiasamy.;Sara Afshar.;Sanghamitra Pati.;J Josh Snodgrass.
来源: Lancet. 2015年385卷9984期2252-3页

2824. ISAT: end of the debate on coiling versus clipping?

作者: Nicolaas A Bakker.;Nic J G M Veeger.;J Marc C Van Dijk.
来源: Lancet. 2015年385卷9984期2251页

2825. ISAT: end of the debate on coiling versus clipping?

作者: Miikka Korja.
来源: Lancet. 2015年385卷9984期2250-1页

2826. Global health security: a flawed SDG framework.

作者: James Smith.
来源: Lancet. 2015年385卷9984期2249页

2827. Evidence-informed response to illicit drugs in Indonesia.

作者: Irwanto.;Dewa N Wirawan.;Ignatius Praptoraharjo.;Sulistyowati Irianto.;Siti Musdah Mulia.
来源: Lancet. 2015年385卷9984期2249-50页

2828. Alexander Rich.

作者: Alison Snyder.
来源: Lancet. 2015年385卷9984期2248页

2829. First, do no harm.

作者: Suzanne O'Sullivan.
来源: Lancet. 2015年385卷9984期2246-7页

2830. Susan Jebb: nutritionist with a scientific passion about food.

作者: Geoff Watts.
来源: Lancet. 2015年385卷9984期2245页

2831. Slovak bribery case sparks wider debate in eastern Europe.

作者: Ed Holt.
来源: Lancet. 2015年385卷9984期2242页

2832. Vaccine shortage threatens spread of meningitis in Niger.

作者: John Maurice.
来源: Lancet. 2015年385卷9984期2241页

2833. Nordic countries divided over Global Financing Facility.

作者: Ann Danaiya Usher.
来源: Lancet. 2015年385卷9984期2239-40页

2834. New guidelines for prevention and management of implantable cardiac electronic device-related infection.

作者: Jonathan A T Sandoe.;Gavin Barlow.;John B Chambers.;Michael Gammage.;Achyut Guleri.;Philip Howard.;Ewan Olson.;John D Perry.;Bernard D Prendergast.;Michael J Spry.;Richard P Steeds.;Muzahir H Tayebjee.;Richard Watkin.
来源: Lancet. 2015年385卷9984期2225-6页

2835. Air pollution at the forefront of global health.

来源: Lancet. 2015年385卷9984期2224页

2836. Emergency care in Northern Ireland: a human rights issue.

来源: Lancet. 2015年385卷9984期2224页

2837. Genetics in medicine--progress and pitfalls.

来源: Lancet. 2015年385卷9984期2223页

2838. Safety, tolerability, and efficacy of idarucizumab for the reversal of the anticoagulant effect of dabigatran in healthy male volunteers: a randomised, placebo-controlled, double-blind phase 1 trial.

作者: Stephan Glund.;Joachim Stangier.;Michael Schmohl.;Dietmar Gansser.;Stephen Norris.;Joanne van Ryn.;Benjamin Lang.;Steven Ramael.;Viktoria Moschetti.;Fredrik Gruenenfelder.;Paul Reilly.;Jörg Kreuzer.
来源: Lancet. 2015年386卷9994期680-90页
Idarucizumab is a monoclonal antibody fragment that binds dabigatran with high affinity in a 1:1 molar ratio. We investigated the safety, tolerability, and efficacy of increasing doses of idarucizumab for the reversal of anticoagulant effects of dabigatran in a two-part phase 1 study (rising-dose assessment and dose-finding, proof-of-concept investigation). Here we present the results of the proof-of-concept part of the study.

2839. Antidotes for anticoagulants: a long way to go.

作者: Tanja A Treschan.;Martin Beiderlinden.
来源: Lancet. 2015年386卷9994期634-6页

2840. Responsibility and accountability for well informed health-care decisions: a global challenge.

作者: Gro Jamtvedt.;Marianne Klemp.;Berit Mørland.;Magne Nylenna.
来源: Lancet. 2015年386卷9995期826-8页
共有 132541 条符合本次的查询结果， 用时 3.7638277 秒